EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
23 hedge funds and large institutions have $50.9M invested in Eucrates Biomedical Acquisition Corp. Unit in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-14
Holders Change %
-37.84%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
6
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
BlackRock
New York
|
-$9.86M |
2 |
6CM
683 Capital Management
New York
|
-$6.4M |
3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$3.78M |
4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.2M |
5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.2M |